Founder Intelligence

Ross Upton

Advancing technology at Ultromics requires rigorous software engineering, disciplined execution, and solving real operational bottlenecks for enterprise users.

Role
Founder
Company
Ultromics
Country
United Kingdom
Company founded
2017
Status
Active

Known for

Ultromics provides enterprise-grade artificial intelligence solutions, delivering specialized Ultromics Platform technology designed to optimize mission-critical workflows…

Ecosystem Connection Map

How this founder connects across companies, products, industries, and research on Brel.

Overview

Structured founder intelligence — role, focus, and why this person matters in the AI ecosystem.

Ross Upton serves as Founder at Ultromics in United Kingdom. Under this leadership, the organization focuses on developing production-grade artificial intelligence systems, enterprise data pipelines, and scalable machine learning workflows designed to solve critical operational bottlenecks.

Why it matters

Ross Upton represents executive and engineering leadership in applied artificial intelligence, driving commercialization from foundational research to production software infrastructure.

Career & Timeline

Verified career context from this founder profile.

Role & Leadership at Ultromics

As Founder, Ross Upton steers the strategic execution, technical roadmap, and architectural foundation of Ultromics. The executive mandate encompasses aligning model training architectures, operational deployment protocols, and developer-facing APIs with enterprise compliance and performance benchmarks.

Technical Contributions & Industry Context

Ross Upton's technical stewardship at Ultromics addresses core infrastructure challenges in the broader AI ecosystem. By prioritizing verifiable model outputs, robust serving infrastructure, and efficient developer integrations, Ultromics provides specialized capabilities in modern intelligent computing.

  • Company founded 2017 · founded Ultromics was founded in 2017 per the company profile source on file. Source
  • 2017: Ultromics founded in Oxford by Ross Upton, PhD, spinning out of University of Oxford research with Professor Paul Leeson. 2017 · development Source
  • November 14, 2019: FDA 510(k) clearance for EchoGo Core strain and ejection fraction analysis. 2019 · development Source
  • Funding 2025 · funding July 31, 2025: Ultromics raised $55 million Series C co-led by L&G, Allegis Capital, and Lightrock. Source
  • 2025u20132026: EchoGo Heart Failure probability scoring and cardiac amyloidosis models expanded with Medicare reimbursement. 2025 · development Source

Companies

Organizations connected to this founder in the Brel graph.

Products

Products and platforms linked to this founder or their organization.

Technologies & Expertise

Verified technology terms linked to this founder.

Industries & Use Cases

Sectors and use cases connected to this founder profile.

Industries

Use cases

Funding

Verified funding disclosures from the connected company profile.

  • July 31, 2025: Ultromics raised $55 million Series C co-led by L&G, Allegis Capital, and Lightrock.

Latest Developments

Recent milestones from the connected organization.

  • 2025–2026: EchoGo Heart Failure probability scoring and cardiac amyloidosis models expanded with Medicare reimbursement. Latest
  • Development 2017 · development Source

Related Intelligence

Reports and insights editorially linked to this founder.

FAQ

Answers restated from verified fields on this profile.

Who is Ross Upton?

Ross Upton is a technology leader and entrepreneur currently serving as Founder at Ultromics.

What company is Ross Upton associated with?

Ross Upton is associated with Ultromics, leading product and technical initiatives.

Where is Ross Upton based?

Ross Upton is based in United Kingdom.

What are Ross Upton's key contributions to the industry?

Ross Upton focuses on scalable software architecture, enterprise product development, and applied artificial intelligence leadership at Ultromics.

Sources & Verification

Verified
Last reviewed Aug 2026

Primary sources

In this profile